Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

538 ARTÍCULOS , VIENDO DEL 136 AL 150

The Effect of Atomoxetin Use in the Treatment of Attention-Deficit/Hyperactivity Disorder on the Symptoms of Restless Legs Syndrome: A Case Report

Baykal S, Karakurt MN.

Clin Neuropharmacol. 2017 Mar/Apr;40(2):93-94. doi: 10.1097/WNF.0000000000000203.

[Sleep apnoea-hypopnoea syndrome and narcolepsy. Description of a series of hospital patients]

Abenza-Abildua MJ, Lores-Gutierrez V, Ramirez-Prieto MT, Miralles-Martinez A, Prieto-Palacio M, Cordero-Martin G, Algarra-Lucas C, Gomez-Acena A, Jimeno-Montero C, Gutierrez-Cueto G, Macon-Liquete E, Bathal-Guede B, Garcia-De Gregorio JA, Perez-Villena A, Herreros-Fernandez ML, Arpa-Gutierrez FJ.

Rev Neurol. 2017 Oct 1;65(7):289-294.

Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management

Wijemanne S, Ondo W.

Pract Neurol. 2017 Dec;17(6):444-452. doi: 10.1136/practneurol-2017-001762. Epub 2017 Nov 2.

Stiff person case misdiagnosed as conversion disorder: A case report

Razmeh S, Habibi AH, Sina F, Alizadeh E, Eslami M.

Caspian J Intern Med. 2017 Fall;8(4):329-331. doi: 10.22088/cjim.8.4.329.

Consensus Paper: Towards a Systems-Level View of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and Cortex

Caligiore D, Pezzulo G, Baldassarre G, Bostan AC, Strick PL, Doya K, Helmich RC, Dirkx M, Houk J, Jörntell H, Lago-Rodriguez A, Galea JM, Miall RC, Popa T, Kishore A, Verschure PF, Zucca R, Herreros I.

Cerebellum. 2017 Feb;16(1):203-229. doi: 10.1007/s12311-016-0763-3.

Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease

Mondragón-Rodríguez S, Perry G, Pena-Ortega F, Williams S.

Curr Alzheimer Res. 2017;14(1):40-46. doi: 10.2174/1567205013666160819131336.

Deep Brain Stimulation for Alzheimer's Disease

Xu DS, Ponce FA.

Curr Alzheimer Res. 2017;14(4):356-361. doi: 10.2174/1567205013666161014124945.

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole

Selfani K, Soland VL, Chouinard S, Huot P.

Neurologist. 2017 Jan;22(1):24-28. doi: 10.1097/NRL.0000000000000096.

Systematic review of severity scales and screening instruments for tics: Critique and recommendations

Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2017 Mar;32(3):467-473. doi: 10.1002/mds.26891. Epub 2017 Jan 10.

Movement disorders in 2016: Progress in Parkinson disease and other movement disorders

Jankovic J.

Nat Rev Neurol. 2017 Feb;13(2):76-78. doi: 10.1038/nrneurol.2016.204. Epub 2017 Jan 13.

The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies

Erro R, Bhatia KP, Espay AJ, Striano P.

Mov Disord. 2017 Mar;32(3):310-318. doi: 10.1002/mds.26901. Epub 2017 Jan 16.

Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment

Senek M, Aquilonius SM, Askmark H, Bergquist F, Constantinescu R, Ericsson A, Lycke S, Medvedev A, Memedi M, Ohlsson F, Spira J, Westin J, Nyholm D.

Eur J Clin Pharmacol. 2017 May;73(5):563-571. doi: 10.1007/s00228-017-2196-4. Epub 2017 Jan 18.

Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research

Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ, Richfield EW, Bekelman D, Kutner JS, Miyasaki J.

Parkinsonism Relat Disord. 2017 Apr;37:19-26. doi: 10.1016/j.parkreldis.2017.01.008. Epub 2017 Jan 11.

Essential pitfalls in "essential" tremor

Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A, Bhatia KP.

Mov Disord. 2017 Mar;32(3):325-331. doi: 10.1002/mds.26919. Epub 2017 Jan 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias